Common antibiotic could help stroke patients recover

NCT ID NCT07526987

Recruiting now Disease control Sponsor: Beijing Tiantan Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 02, 2026 · Updated 3 times

Summary

This study tests whether the antibiotic minocycline can improve recovery in people having an ischemic stroke. About 934 adults will receive either minocycline or a placebo, in addition to standard clot-busting medication. The goal is to see if minocycline leads to better functional outcomes, like being able to live independently after the stroke.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: minocycline (an antibiotic)
What this could lead to: If it works, this could provide a simple, widely available add-on treatment to improve recovery after a stroke.
What could go wrong: This is a large Phase 3 trial, but minocycline has not been proven effective for stroke before. It may not improve outcomes and could have side effects like dizziness or nausea.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHAEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cyclopia sequence ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ISCHAEMIC STROKE

Contacts and locations

Locations

Beijing Tiantan Hospital
NOT_YET_RECRUITING

Beijing, 100070, China
Guanxian People's Hospital
RECRUITING

Liaocheng, Shandong, 252500, China
Liaocheng Third People's Hospital
RECRUITING

Liaocheng, Shandong, 252000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.